Press-release for stocks for fate

Prices are updated after-hours

symbols : Fate

save search

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| -5.02% | O: 0.21% H: 4.8% C: -5.22%
ft819 presentation for meeting therapeutics

Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| -33.24% | O: -0.29% H: 7.52% C: 3.39%
conference therapeutics

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| -33.24% | O: -0.29% H: 7.52% C: 3.39%
award nasdaq therapeutics employee

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
Published: 2024-03-19 (Crawled : 12:30) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| -35.51% | O: -2.98% H: 6.59% C: 2.49%
million offering therapeutics

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| -34.49% | O: 3.32% H: 12.71% C: 11.45%
award nasdaq therapeutics employee

Fate Therapeutics to Present at Upcoming March Investor Conferences
Published: 2024-03-01 (Crawled : 13:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| -35.97% | O: 0.99% H: 8.94% C: 8.1%
therapeutics

Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Published: 2024-02-26 (Crawled : 21:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| -34.68% | O: 8.78% H: 14.15% C: -1.32%
business year therapeutics financial results

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-15 (Crawled : 13:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| -30.05% | O: 2.16% H: 8.6% C: 6.79%
conference year therapeutics financial results

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-02 (Crawled : 21:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| Email alert Add to watchlist
nasdaq awards therapeutics employee

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| 20.42% | O: 0.8% H: 13.16% C: 8.42%
ft825 tumors trial therapeutics advanced

Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-13 (Crawled : 22:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| 69.4% | O: 5.22% H: 7.09% C: 5.67%
nasdaq grants therapeutics employee

Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results
Published: 2023-10-25 (Crawled : 12:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| 134.02% | O: 0.52% H: 1.03% C: -7.69%
conference therapeutics financial results

SHORELINE BIOSCIENCES WINS A COMPREHENSIVE SUMMARY JUDGEMENT VICTORY ON ALL CLAIMS BROUGHT BY FATE THERAPEUTICS AND WHITEHEAD INSTITUTE ON IPSC GENERATION AND USE
Published: 2023-09-07 (Crawled : 12:00) - prnewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| 74.62% | O: -1.92% H: 0.39% C: -3.14%
institute therapeutics

Fate Therapeutics to Present at Upcoming September Investor Conferences
Published: 2023-08-31 (Crawled : 12:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| 71.97% | O: 0.0% H: 0.76% C: -4.92%
therapeutics

Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results
Published: 2023-07-28 (Crawled : 12:00) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| 10.73% | O: 2.44% H: 2.62% C: 0.24%
conference therapeutics financial results

Fate Therapeutics to Present at Upcoming June Investor Conferences
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
FATE | News | $4.21 -7.27% 1.2M

Health Technology

| -8.47% | O: 0.0% H: 6.25% C: 1.81%
therapeutics